Savant Capital LLC Trims Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Savant Capital LLC reduced its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 12.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 35,668 shares of the medical instruments supplier’s stock after selling 5,205 shares during the quarter. Savant Capital LLC’s holdings in DENTSPLY SIRONA were worth $1,269,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in XRAY. Russell Investments Group Ltd. boosted its position in DENTSPLY SIRONA by 5.3% during the 4th quarter. Russell Investments Group Ltd. now owns 900,306 shares of the medical instruments supplier’s stock valued at $32,042,000 after acquiring an additional 45,711 shares in the last quarter. Headlands Technologies LLC purchased a new stake in DENTSPLY SIRONA in the fourth quarter worth $30,000. Sonen Capital LLC purchased a new stake in DENTSPLY SIRONA in the fourth quarter worth $259,000. GAMMA Investing LLC bought a new position in DENTSPLY SIRONA in the fourth quarter worth $55,000. Finally, Parkside Financial Bank & Trust boosted its holdings in shares of DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 292 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Trading Down 0.3 %

Shares of DENTSPLY SIRONA stock opened at $28.29 on Friday. The stock has a market capitalization of $5.87 billion, a PE ratio of -64.29, a P/E/G ratio of 1.15 and a beta of 1.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.95. The company’s fifty day simple moving average is $32.13 and its 200-day simple moving average is $32.71. DENTSPLY SIRONA Inc. has a 1-year low of $26.27 and a 1-year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. The firm had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.39 earnings per share. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a $0.16 dividend. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.26%. DENTSPLY SIRONA’s dividend payout ratio is -145.45%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on XRAY shares. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a research note on Friday. Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an “outperform” rating and a $42.00 price target on the stock. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a report on Friday. Finally, Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research report on Friday. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA has an average rating of “Moderate Buy” and an average target price of $36.90.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.